Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans

Somatic heterozygous TET2 loss drives clonal hematopoiesis, which is linked to malignant cell degeneration and potentially cardiovascular disease. Here, the authors investigate the molecular impact of a germline TET2 mutation in a lymphoma family, finding elevated blood DNA methylation levels and no...

Full description

Bibliographic Details
Main Authors: Eevi Kaasinen, Outi Kuismin, Kristiina Rajamäki, Heikki Ristolainen, Mervi Aavikko, Johanna Kondelin, Silva Saarinen, Davide G. Berta, Riku Katainen, Elina A. M. Hirvonen, Auli Karhu, Aurora Taira, Tomas Tanskanen, Amjad Alkodsi, Minna Taipale, Ekaterina Morgunova, Kaarle Franssila, Rainer Lehtonen, Markus Mäkinen, Kristiina Aittomäki, Aarno Palotie, Mitja I. Kurki, Olli Pietiläinen, Morgane Hilpert, Elmo Saarentaus, Jaakko Niinimäki, Juhani Junttila, Kari Kaikkonen, Pia Vahteristo, Radek C. Skoda, Mikko R. J. Seppänen, Kari K. Eklund, Jussi Taipale, Outi Kilpivaara, Lauri A. Aaltonen
Format: Article
Language:English
Published: Nature Portfolio 2019-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-09198-7
_version_ 1818342624595017728
author Eevi Kaasinen
Outi Kuismin
Kristiina Rajamäki
Heikki Ristolainen
Mervi Aavikko
Johanna Kondelin
Silva Saarinen
Davide G. Berta
Riku Katainen
Elina A. M. Hirvonen
Auli Karhu
Aurora Taira
Tomas Tanskanen
Amjad Alkodsi
Minna Taipale
Ekaterina Morgunova
Kaarle Franssila
Rainer Lehtonen
Markus Mäkinen
Kristiina Aittomäki
Aarno Palotie
Mitja I. Kurki
Olli Pietiläinen
Morgane Hilpert
Elmo Saarentaus
Jaakko Niinimäki
Juhani Junttila
Kari Kaikkonen
Pia Vahteristo
Radek C. Skoda
Mikko R. J. Seppänen
Kari K. Eklund
Jussi Taipale
Outi Kilpivaara
Lauri A. Aaltonen
author_facet Eevi Kaasinen
Outi Kuismin
Kristiina Rajamäki
Heikki Ristolainen
Mervi Aavikko
Johanna Kondelin
Silva Saarinen
Davide G. Berta
Riku Katainen
Elina A. M. Hirvonen
Auli Karhu
Aurora Taira
Tomas Tanskanen
Amjad Alkodsi
Minna Taipale
Ekaterina Morgunova
Kaarle Franssila
Rainer Lehtonen
Markus Mäkinen
Kristiina Aittomäki
Aarno Palotie
Mitja I. Kurki
Olli Pietiläinen
Morgane Hilpert
Elmo Saarentaus
Jaakko Niinimäki
Juhani Junttila
Kari Kaikkonen
Pia Vahteristo
Radek C. Skoda
Mikko R. J. Seppänen
Kari K. Eklund
Jussi Taipale
Outi Kilpivaara
Lauri A. Aaltonen
author_sort Eevi Kaasinen
collection DOAJ
description Somatic heterozygous TET2 loss drives clonal hematopoiesis, which is linked to malignant cell degeneration and potentially cardiovascular disease. Here, the authors investigate the molecular impact of a germline TET2 mutation in a lymphoma family, finding elevated blood DNA methylation levels and no predisposition to atherosclerosis
first_indexed 2024-12-13T16:17:39Z
format Article
id doaj.art-46989eed5d5545f397b38c9c2843f70f
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-13T16:17:39Z
publishDate 2019-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-46989eed5d5545f397b38c9c2843f70f2022-12-21T23:38:49ZengNature PortfolioNature Communications2041-17232019-03-0110111710.1038/s41467-019-09198-7Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humansEevi Kaasinen0Outi Kuismin1Kristiina Rajamäki2Heikki Ristolainen3Mervi Aavikko4Johanna Kondelin5Silva Saarinen6Davide G. Berta7Riku Katainen8Elina A. M. Hirvonen9Auli Karhu10Aurora Taira11Tomas Tanskanen12Amjad Alkodsi13Minna Taipale14Ekaterina Morgunova15Kaarle Franssila16Rainer Lehtonen17Markus Mäkinen18Kristiina Aittomäki19Aarno Palotie20Mitja I. Kurki21Olli Pietiläinen22Morgane Hilpert23Elmo Saarentaus24Jaakko Niinimäki25Juhani Junttila26Kari Kaikkonen27Pia Vahteristo28Radek C. Skoda29Mikko R. J. Seppänen30Kari K. Eklund31Jussi Taipale32Outi Kilpivaara33Lauri A. Aaltonen34Department of Medical and Clinical Genetics, University of HelsinkiDepartment of Clinical Genetics, Oulu University HospitalDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiGenome-Scale Biology, Research Programs Unit, University of HelsinkiDepartment of Biosciences and Nutrition, Karolinska InstitutetDepartment of Biosciences and Nutrition, Karolinska InstitutetHUSLAB, Helsinki University HospitalGenome-Scale Biology, Research Programs Unit, University of HelsinkiCancer and Translational Medicine Research Unit, University of OuluDepartment of Clinical Genetics, Helsinki University HospitalInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of HelsinkiAnalytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General HospitalThe Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and HarvardDepartment of Biomedicine, Experimental Hematology, University Hospital Basel and University of BaselInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of HelsinkiMedical Research Center Oulu, Oulu University Hospital and University of OuluResearch Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of OuluResearch Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of OuluDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Biomedicine, Experimental Hematology, University Hospital Basel and University of BaselAdult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University HospitalClinicum, University of HelsinkiGenome-Scale Biology, Research Programs Unit, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiDepartment of Medical and Clinical Genetics, University of HelsinkiSomatic heterozygous TET2 loss drives clonal hematopoiesis, which is linked to malignant cell degeneration and potentially cardiovascular disease. Here, the authors investigate the molecular impact of a germline TET2 mutation in a lymphoma family, finding elevated blood DNA methylation levels and no predisposition to atherosclerosishttps://doi.org/10.1038/s41467-019-09198-7
spellingShingle Eevi Kaasinen
Outi Kuismin
Kristiina Rajamäki
Heikki Ristolainen
Mervi Aavikko
Johanna Kondelin
Silva Saarinen
Davide G. Berta
Riku Katainen
Elina A. M. Hirvonen
Auli Karhu
Aurora Taira
Tomas Tanskanen
Amjad Alkodsi
Minna Taipale
Ekaterina Morgunova
Kaarle Franssila
Rainer Lehtonen
Markus Mäkinen
Kristiina Aittomäki
Aarno Palotie
Mitja I. Kurki
Olli Pietiläinen
Morgane Hilpert
Elmo Saarentaus
Jaakko Niinimäki
Juhani Junttila
Kari Kaikkonen
Pia Vahteristo
Radek C. Skoda
Mikko R. J. Seppänen
Kari K. Eklund
Jussi Taipale
Outi Kilpivaara
Lauri A. Aaltonen
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
Nature Communications
title Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
title_full Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
title_fullStr Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
title_full_unstemmed Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
title_short Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
title_sort impact of constitutional tet2 haploinsufficiency on molecular and clinical phenotype in humans
url https://doi.org/10.1038/s41467-019-09198-7
work_keys_str_mv AT eevikaasinen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT outikuismin impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT kristiinarajamaki impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT heikkiristolainen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT merviaavikko impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT johannakondelin impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT silvasaarinen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT davidegberta impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT rikukatainen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT elinaamhirvonen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT aulikarhu impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT aurorataira impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT tomastanskanen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT amjadalkodsi impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT minnataipale impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT ekaterinamorgunova impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT kaarlefranssila impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT rainerlehtonen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT markusmakinen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT kristiinaaittomaki impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT aarnopalotie impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT mitjaikurki impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT ollipietilainen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT morganehilpert impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT elmosaarentaus impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT jaakkoniinimaki impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT juhanijunttila impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT karikaikkonen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT piavahteristo impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT radekcskoda impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT mikkorjseppanen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT karikeklund impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT jussitaipale impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT outikilpivaara impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans
AT lauriaaaltonen impactofconstitutionaltet2haploinsufficiencyonmolecularandclinicalphenotypeinhumans